Hadas Reuveni
Chief Tech/Sci/R&D Officer presso PURPLE BIOTECH LTD
Profilo
Hadas Reuveni was the founder of AngioB Ltd.
where she held the title of Chief Scientific Officer from 2006 to 2010.
Dr. Reuveni is also the founder of Tyrnovo Ltd.
She is currently the Vice President-Research & Development at Purple Biotech Ltd.
since 2017.
Dr. Reuveni's former positions include Chief Executive Officer at NovoTyr Therapeutics Ltd.
from 2005 to 2012 and Director-Research & Development at Keryx Biopharmaceuticals, Inc. from 2001 to 2004.
Dr. Reuveni received her undergraduate, graduate, and doctorate degrees from The Hebrew University of Jerusalem.
Posizioni attive di Hadas Reuveni
| Società | Posizione | Inizio |
|---|---|---|
| PURPLE BIOTECH LTD | Chief Tech/Sci/R&D Officer | 01/01/2017 |
Tyrnovo Ltd.
 Tyrnovo Ltd. Drugstore ChainsRetail Trade Tyrnovo Ltd. operates as a pharmaceutical company. It develops drugs that eliminates a key protein in cancer, resulting in improved cancer therapy, prevention of drug resistance, and increased life expectancy. The company was founded by Hadas Reuveni and is headquartered in Herzliya, Israel. | Chief Executive Officer | - |
Precedenti posizioni note di Hadas Reuveni
| Società | Posizione | Fine |
|---|---|---|
NovoTyr Therapeutics Ltd.
 NovoTyr Therapeutics Ltd. Medical SpecialtiesHealth Technology NovoTyr Therapeutics Ltd. develops insulin-like growth factor receptor inhibitors. It provides services in the biotechnology, drug development, cancer and other proliferative disease sectors. The company was founded by Alexander Levitzki in 2005 and is headquartered in Kiryat Shmona, Israel | Chief Executive Officer | 01/01/2012 |
| KERYX BIOPHARMACEUTICALS | Chief Tech/Sci/R&D Officer | 01/01/2004 |
AngioB Ltd.
 AngioB Ltd. Medical SpecialtiesHealth Technology AngioB Ltd. developed treatments for ischemic heart conditions. It also developed proprietary novel pro-angiogenic drugs to treat cardiovascular diseases and peripheral ischemic disorders. The company started in-vivo experiments to evaluate the pro-angiogenic potential of its lead compound in clinical-relevant models. AngioB was founded in July 2006 and was headquartered in Kiryat Shmona, Israel | Founder | - |
Formazione di Hadas Reuveni
| The Hebrew University of Jerusalem | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PURPLE BIOTECH LTD | Health Technology |
| Aziende private | 4 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
AngioB Ltd.
AngioB Ltd. Medical SpecialtiesHealth Technology AngioB Ltd. developed treatments for ischemic heart conditions. It also developed proprietary novel pro-angiogenic drugs to treat cardiovascular diseases and peripheral ischemic disorders. The company started in-vivo experiments to evaluate the pro-angiogenic potential of its lead compound in clinical-relevant models. AngioB was founded in July 2006 and was headquartered in Kiryat Shmona, Israel | Health Technology |
NovoTyr Therapeutics Ltd.
NovoTyr Therapeutics Ltd. Medical SpecialtiesHealth Technology NovoTyr Therapeutics Ltd. develops insulin-like growth factor receptor inhibitors. It provides services in the biotechnology, drug development, cancer and other proliferative disease sectors. The company was founded by Alexander Levitzki in 2005 and is headquartered in Kiryat Shmona, Israel | Health Technology |
Tyrnovo Ltd.
Tyrnovo Ltd. Drugstore ChainsRetail Trade Tyrnovo Ltd. operates as a pharmaceutical company. It develops drugs that eliminates a key protein in cancer, resulting in improved cancer therapy, prevention of drug resistance, and increased life expectancy. The company was founded by Hadas Reuveni and is headquartered in Herzliya, Israel. | Retail Trade |
- Borsa valori
- Insiders
- Hadas Reuveni
